search
Back to results

Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2 (LBMI)

Primary Purpose

Obesity

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
LAP-BAND® Adjustable Gastric Band (LAGB®)
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Obesity, 50 lbs overweight

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be at least 18 and equal to or less than 60 years of age.
  • BMI of at least 30 and maximum BMI of 40 with co-morbidities
  • Willingness to comply with dietary restrictions required by the protocol
  • History of obesity for at least 5 years
  • History of at least 6 months of documented failures with traditional non-surgical weight loss methods
  • Willingness to follow protocol requirements
  • If female with childbearing potential, using an appropriate form of contraception

Exclusion Criteria:

  • Age less than 18, age greater than 60
  • Pregnancy
  • History of major depressive disorder or psychosis
  • Previous bariatric surgery or previous gastric surgery
  • Presence of achalasia
  • Presence of portal hypertension, cirrhosis, and/or varices
  • Patient with inflammatory disease of the gastrointestinal tract such as Crohn's Disease
  • Patients with autoimmune connective tissue disorders
  • Patients with acute abdominal infections
  • Any condition that, in the judgment of the investigator, would place a subject at undue risk, or potentially compromise the results or interpretation of the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    LAGB for low BMI patients

    Arm Description

    the LAP-BAND® Adjustable Gastric Band (LAGB®) for patients with BMI between 30-40 kg/m2 with co-morbidities

    Outcomes

    Primary Outcome Measures

    To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery
    Change in weight from baseline at 5 years by calculating the percentage of the weight loss from the total excess weight.

    Secondary Outcome Measures

    Level of LDL (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery
    Change in level of LDL from baseline at 5 years
    Level of Triglycerides (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery
    Change in level of Triglycerides from baseline at 5 years
    Level of HbA1c (Blood Test for Diabetes) After Laparoscopic Adjustable Gastric Band Surgery
    Change in level of HbA1c from baseline at 5 years

    Full Information

    First Posted
    December 21, 2007
    Last Updated
    March 16, 2015
    Sponsor
    NYU Langone Health
    Collaborators
    Allergan
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00580502
    Brief Title
    Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2
    Acronym
    LBMI
    Official Title
    A Prospective Study to Evaluate the Safety and Efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) Operations for Patients With BMI Between 30-40 kg/m2 With Co-morbidities
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2004 (undefined)
    Primary Completion Date
    September 2012 (Actual)
    Study Completion Date
    September 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    NYU Langone Health
    Collaborators
    Allergan

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    This study is to evaluate the safety and efficacy of Gastric Banding for patients with body mass index (BMI) between 30-40 kg/m2 with medical conditions related to obesity.
    Detailed Description
    TITLE OF STUDY:A prospective study to evaluate the safety and efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) operations for patients with BMI between 30-40 kg/m2 with co-morbidities CLINICAL PHASE: Phase III new indication for use of the device not yet approved by FDA STUDY OBJECTIVES To determine the safety and efficacy of the LAP-BAND® Adjustable Gastric Band (LAGB®) for patients with BMI between 30-40 kg/m2 with co-morbidities To determine long-term effects on patients' co-morbidities STUDY VARIABLES: Morbidity & mortality, percent of excess weight loss, nutritional status, improvement of pre-operative co-morbidities, weight loss maintained, and quality of life evaluation DESIGN: Prospective single center study

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obesity
    Keywords
    Obesity, 50 lbs overweight

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2, Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    50 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    LAGB for low BMI patients
    Arm Type
    Experimental
    Arm Description
    the LAP-BAND® Adjustable Gastric Band (LAGB®) for patients with BMI between 30-40 kg/m2 with co-morbidities
    Intervention Type
    Device
    Intervention Name(s)
    LAP-BAND® Adjustable Gastric Band (LAGB®)
    Intervention Description
    Bariatric surgery for patient whose BMI is between 30 and 40 kg/m^2
    Primary Outcome Measure Information:
    Title
    To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery
    Description
    Change in weight from baseline at 5 years by calculating the percentage of the weight loss from the total excess weight.
    Time Frame
    5 years
    Secondary Outcome Measure Information:
    Title
    Level of LDL (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery
    Description
    Change in level of LDL from baseline at 5 years
    Time Frame
    5 years
    Title
    Level of Triglycerides (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery
    Description
    Change in level of Triglycerides from baseline at 5 years
    Time Frame
    5 years
    Title
    Level of HbA1c (Blood Test for Diabetes) After Laparoscopic Adjustable Gastric Band Surgery
    Description
    Change in level of HbA1c from baseline at 5 years
    Time Frame
    5 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Be at least 18 and equal to or less than 60 years of age. BMI of at least 30 and maximum BMI of 40 with co-morbidities Willingness to comply with dietary restrictions required by the protocol History of obesity for at least 5 years History of at least 6 months of documented failures with traditional non-surgical weight loss methods Willingness to follow protocol requirements If female with childbearing potential, using an appropriate form of contraception Exclusion Criteria: Age less than 18, age greater than 60 Pregnancy History of major depressive disorder or psychosis Previous bariatric surgery or previous gastric surgery Presence of achalasia Presence of portal hypertension, cirrhosis, and/or varices Patient with inflammatory disease of the gastrointestinal tract such as Crohn's Disease Patients with autoimmune connective tissue disorders Patients with acute abdominal infections Any condition that, in the judgment of the investigator, would place a subject at undue risk, or potentially compromise the results or interpretation of the study
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Christine Ren-Fielding, M.D.
    Organizational Affiliation
    NYUSOM
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Links:
    URL
    http://nyuweightloss.org
    Description
    NYU Program for Surgical Weight Loss

    Learn more about this trial

    Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2

    We'll reach out to this number within 24 hrs